TIDMHLN TIDMGSK

RNS Number : 2052A

Haleon PLC

18 January 2024

18 January 2024

HALEON PLC

("Haleon" or "the Company")

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BMX86B70

Issuer Name

HALEON PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

GSK plc

City of registered office (if applicable)

BRENTFORD

Country of registered office (if applicable)

United Kingdom

 
  Name                                        City of registered office    Country of registered office 
   GSK (No.1) Scottish Limited Partnership     Edinburgh                    Scotland 
                                            ===========================  ============================== 
   GSK LP Limited                              London                       England 
                                            ===========================  ============================== 
   GSK GP 1 Limited                            Edinburgh                    Scotland 
                                            ===========================  ============================== 
 

4. Details of the shareholder

 
  Name                         City of registered office    Country of registered office 
   Vidacos Nominees Limited     London                       England 
                             ===========================  ============================== 
 

5. Date on which the threshold was crossed or reached

17-Jan-2024

6. Date on which Issuer notified

18-Jan-2024

7. Total positions of person(s) subject to the notification obligation

 
                          % of voting rights      % of voting rights      Total of both in %      Total number of 
                          attached to shares      through financial       (8.A + 8.B)             voting rights held 
                          (total of 8.A)          instruments (total                              in issuer 
                                                  of 8.B 1 + 8.B 2) 
   Resulting situation 
    on the date on 
    which threshold 
    was crossed or 
    reached                4.170000                0.000000                4.170000                385320110 
                        ======================  ======================  ======================  ====================== 
   Position of 
    previous 
    notification (if 
    applicable)            7.420000                0.000000                7.420000 
                        ======================  ======================  ======================  ====================== 
 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

 
Class/Type of shares    Number of direct        Number of indirect      % of direct voting      % of indirect voting 
ISIN code(if possible)  voting rights (DTR5.1)  voting rights           rights (DTR5.1)         rights (DTR5.2.1) 
                                                (DTR5.2.1) 
GB00BMX86B70               0                       385320110               0.000000                4.170000 
                        ======================  ======================  ======================  ====================== 
Sub Total 8.A              385320110                                       4.170000% 
                        ==============================================  ============================================== 
 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 
Type of financial           Expiration date  Exercise/conversion period  Number of voting rights    % of voting rights 
instrument                                                               that may be acquired if 
                                                                         the instrument is 
                                                                         exercised/converted 
 
Sub Total 8.B1 
                            ===========================================  =========================  ================== 
 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

 
Type of financial   Expiration date  Exercise/conversion  Physical or cash     Number of voting     % of voting rights 
instrument                           period               settlement           rights 
 
Sub Total 8.B2 
                    =========================================================  ===================  ================== 
 

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

 
Ultimate controlling     Name of controlled       % of voting rights if  % of voting rights     Total of both if it 
person                   undertaking              it equals or is        through financial      equals or is higher 
                                                  higher than the        instruments if it      than the notifiable 
                                                  notifiable threshold   equals or is higher    threshold 
                                                                         than the notifiable 
                                                                         threshold 
   GSK plc (Chain 1)                                 2.850000                                      2.850000% 
                                                  =====================  =====================  ====================== 
                            GlaxoSmithKline 
                             Holdings Limited 
   GSK plc (Chain 1)         (Chain 1)               2.850000                                      2.850000% 
                         =======================  =====================  =====================  ====================== 
                            GlaxoSmithKline 
                             Finance plc (Chain 
   GSK plc (Chain 1)         1)                      2.850000                                      2.850000% 
                         =======================  =====================  =====================  ====================== 
                            Glaxo Group Limited 
   GSK plc (Chain 1)         (Chain 1)               2.850000                                      2.850000% 
                         =======================  =====================  =====================  ====================== 
   GSK plc (Chain 2)                                 1.330000                                      1.330000% 
                                                  =====================  =====================  ====================== 
                            GSK LP Limited 
   GSK plc (Chain 2)         (Chain 2)               1.330000                                      1.330000% 
                         =======================  =====================  =====================  ====================== 
                            GSK GP 1 Limited 
   GSK plc (Chain 2)         (Chain 2)               1.330000                                      1.330000% 
                         =======================  =====================  =====================  ====================== 
                            GSK (No. 1) Scottish 
                             Limited Partnership 
   GSK plc (Chain 2)         (Chain 2)               1.330000                                      1.330000% 
                         =======================  =====================  =====================  ====================== 
 

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

GSK plc is making this notification on behalf of itself and on behalf of GSK LP Limited, GSK GP 1 Limited and GSK (No.1) Scottish Limited Partnership.

This notification relates to the sale by GSK (No.1) Scottish Limited Partnership (an entity indirectly wholly-owned by GSK plc) of a portion of its interest in Haleon plc.

GSK GP 1 Limited is the sole general partner of GSK (No.1) Scottish Limited Partnership. GSK LP Limited is the sole limited partner of GSK (No.1) Scottish Limited Partnership.

Glaxo Group Limited and GSK (No.1) Scottish Limited Partnership hold their shares in Haleon plc via a custodian, Vidacos Nominees Limited, which holds the legal title to those shares on their behalf pursuant to a custody arrangement.

12. Date of Completion

18-Jan-2024

13. Place Of Completion

London, England

Amanda Mellor, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLUWVNRSNUAAAR

(END) Dow Jones Newswires

January 18, 2024 12:00 ET (17:00 GMT)

Gsk (LSE:GSK)
過去 株価チャート
から 3 2024 まで 4 2024 Gskのチャートをもっと見るにはこちらをクリック
Gsk (LSE:GSK)
過去 株価チャート
から 4 2023 まで 4 2024 Gskのチャートをもっと見るにはこちらをクリック